The Latin American Association of Cardiac and Endovascular Surgery statement regarding the recently...
The Latin American Association of Cardiac and Endovascular Surgery statement regarding the recently released 2020 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease
About this item
Full title
Author / Creator
Publisher
Sao Paulo: Sociedade Brasileira de Cirurgia Cardiovascular
Journal title
Language
English
Formats
Publication information
Publisher
Sao Paulo: Sociedade Brasileira de Cirurgia Cardiovascular
Subjects
More information
Scope and Contents
Contents
Furthermore, the age range used to support TAVI is well below the mean age of the low-risk trials (73 years old for PARTNER 3 and 74 years old for EVOLUT Low Risk) and there is absolutely no reference to support this range defined by the authors. [...]LACES considers an important methodological flaw subject to high risk of reversal, to recommend as...
Alternative Titles
Full title
The Latin American Association of Cardiac and Endovascular Surgery statement regarding the recently released 2020 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b4e8e602da7847dc87c460f6f8cc7484
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b4e8e602da7847dc87c460f6f8cc7484
Other Identifiers
ISSN
1678-9741,0102-7638
E-ISSN
1678-9741
DOI
10.21470/1678-9741-2021-0952
